{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Disease%2C+Chronic", "query": { "condition": "Disease, Chronic" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11390, "total_pages": 1139, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Disease%2C+Chronic&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-21T23:31:45.777Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00001128", "title": "Treatment of Chronic Cryptosporidiosis in AIDS Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cryptosporidiosis", "HIV Infections" ], "interventions": [ { "name": "Interleukin-12", "type": "DRUG" }, { "name": "Paromomycin sulfate", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": null, "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2016-12-14", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001128" }, { "nct_id": "NCT07250828", "title": "Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Painful Diabetic Neuropathy (PDN)", "Diabetic Neuropathy", "Neuropathic Pain", "Chronic Pain" ], "interventions": [ { "name": "BurstDR Spinal Cord Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "TriCity Research Center", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 20, "start_date": "2025-12-15", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Grand Island, Nebraska", "locations": [ { "city": "Grand Island", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07250828" }, { "nct_id": "NCT02825836", "title": "Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Relapsed/Refractory B Cell Malignancies", "Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Treatment-Naive B Cell Malignancies" ], "interventions": [ { "name": "TL-895", "type": "DRUG" }, { "name": "Navtemadlin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Telios Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2016-08-26", "completion_date": "2025-12-01", "has_results": false, "last_update_posted_date": "2023-07-13", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 2, "location_summary": "Columbus, Ohio • Germantown, Tennessee", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Germantown", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02825836" }, { "nct_id": "NCT00419744", "title": "A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Budesonide/formoterol (SYMBICORT) pMDI", "type": "DRUG" }, { "name": "Formoterol Turbuhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1200, "start_date": "2007-01", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2010-09-16", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 92, "location_summary": "Jasper, Alabama • Mobile, Alabama • Tucson, Arizona + 89 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00419744" }, { "nct_id": "NCT06184932", "title": "TeleRehab to Restore Upper Limb Function in People With Chronic TBI", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain Injury", "Upper Extremity Dysfunction", "Disability Physical" ], "interventions": [ { "name": "HAHE", "type": "BEHAVIORAL" }, { "name": "Exergame", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Kessler Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2023-04-01", "completion_date": "2025-03-31", "has_results": false, "last_update_posted_date": "2024-01-05", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "West Orange, New Jersey", "locations": [ { "city": "West Orange", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06184932" }, { "nct_id": "NCT05228132", "title": "The Pristine Post-Market Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Kidney Failure, Chronic", "Hemodialysis Complication", "Hemodialysis Catheter Infection", "Hemodialysis Access Failure", "Central Venous Catheter Related Bloodstream Infection", "End Stage Renal Disease" ], "interventions": [ { "name": "Pristine™ Long-Term Hemodialysis Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "C. R. Bard", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 142, "start_date": "2022-05-16", "completion_date": "2022-09-21", "has_results": true, "last_update_posted_date": "2024-04-11", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 6, "location_summary": "Dothan, Alabama • New Haven, Connecticut • Shreveport, Louisiana + 3 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05228132" }, { "nct_id": "NCT01110863", "title": "Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Lymphocytic Leukemia" ], "interventions": [], "intervention_types": [], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2005-12", "completion_date": "2016-02-12", "has_results": false, "last_update_posted_date": "2021-03-03", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Manhasset, New York", "locations": [ { "city": "Manhasset", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110863" }, { "nct_id": "NCT06840314", "title": "VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Genito-Pelvic Pain/Penetration Disorder", "Dyspareunia", "Vaginismus", "Pelvic Pain", "Vestibulodynia", "Vulvodynia (Chronic Vulvar Pain)" ], "interventions": [ { "name": "Pelvic floor therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 60, "start_date": "2025-03-01", "completion_date": "2026-03", "has_results": false, "last_update_posted_date": "2025-05-21", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06840314" }, { "nct_id": "NCT04601506", "title": "PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Primary Care Providers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid-use Disorder", "Opioid Use", "Opioid Abuse" ], "interventions": [ { "name": "Choice Architecture Nudge", "type": "BEHAVIORAL" }, { "name": "PMP Integration & Nudge", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 472, "start_date": "2020-08-26", "completion_date": "2021-10-01", "has_results": true, "last_update_posted_date": "2024-06-27", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04601506" }, { "nct_id": "NCT01815749", "title": "Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adult Grade III Lymphomatoid Granulomatosis", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Post-transplant Lymphoproliferative Disorder", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Small Lymphocytic Lymphoma", "Refractory Hairy Cell Leukemia", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Testicular Lymphoma", "Waldenström Macroglobulinemia" ], "interventions": [ { "name": "autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells", "type": "BIOLOGICAL" }, { "name": "autologous hematopoietic stem cell transplantation", "type": "PROCEDURE" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "OTHER" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2013-10-08", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-07-21T23:31:45.777Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01815749" } ] }